A citation-based method for searching scientific literature

Agustin Melo-Carrillo, Andrew M Strassman, Rony-Reuven Nir, Aaron J Schain, Rodrigo Noseda, Jennifer Stratton, Rami Burstein. J Neurosci 2017
Times Cited: 86







List of co-cited articles
1056 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.
Agustin Melo-Carrillo, Rodrigo Noseda, Rony-Reuven Nir, Aaron J Schain, Jennifer Stratton, Andrew M Strassman, Rami Burstein. J Neurosci 2017
76
52


CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Lars Edvinsson, Kristian Agmund Haanes, Karin Warfvinge, Diana N Krause. Nat Rev Neurol 2018
357
33

Fremanezumab for the Preventive Treatment of Chronic Migraine.
Stephen D Silberstein, David W Dodick, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. N Engl J Med 2017
320
27

Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.
Sajedeh Eftekhari, Karin Warfvinge, Frank W Blixt, Lars Edvinsson. J Pain 2013
141
25

Pathophysiology of Migraine: A Disorder of Sensory Processing.
Peter J Goadsby, Philip R Holland, Margarida Martins-Oliveira, Jan Hoffmann, Christoph Schankin, Simon Akerman. Physiol Rev 2017
667
25


Activation of central trigeminovascular neurons by cortical spreading depression.
Xichun Zhang, Dan Levy, Vanessa Kainz, Rodrigo Noseda, Moshe Jakubowski, Rami Burstein. Ann Neurol 2011
224
23

Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura.
Jakob Møller Hansen, Anne Werner Hauge, Jes Olesen, Messoud Ashina. Cephalalgia 2010
262
22

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Stewart Tepper, Messoud Ashina, Uwe Reuter, Jan L Brandes, David Doležil, Stephen Silberstein, Paul Winner, Dean Leonardi, Daniel Mikol, Robert Lenz. Lancet Neurol 2017
343
22

A Controlled Trial of Erenumab for Episodic Migraine.
Peter J Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H Bonner, Feng Zhang, Sandhya Sapra, Hernan Picard, Daniel D Mikol, Robert A Lenz. N Engl J Med 2017
388
22

C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system.
Jacob C A Edvinsson, Karin Warfvinge, Diana N Krause, Frank W Blixt, Majid Sheykhzade, Lars Edvinsson, Kristian A Haanes. J Headache Pain 2019
41
46

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
Jes Olesen, Hans-Christoph Diener, Ingo W Husstedt, Peter J Goadsby, David Hall, Ulrich Meier, Stephane Pollentier, Lynna M Lesko. N Engl J Med 2004
868
19

Calcitonin gene-related peptide: physiology and pathophysiology.
F A Russell, R King, S-J Smillie, X Kodji, S D Brain. Physiol Rev 2014
515
18

Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.
S Eftekhari, C A Salvatore, A Calamari, S A Kane, J Tajti, L Edvinsson. Neuroscience 2010
210
18

CGRP may play a causative role in migraine.
L H Lassen, P A Haderslev, V B Jacobsen, H K Iversen, B Sperling, J Olesen. Cephalalgia 2002
636
18

Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura.
Xichun Zhang, Dan Levy, Rodrigo Noseda, Vanessa Kainz, Moshe Jakubowski, Rami Burstein. J Neurosci 2010
227
18

Migraine: multiple processes, complex pathophysiology.
Rami Burstein, Rodrigo Noseda, David Borsook. J Neurosci 2015
343
18

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
David W Dodick, Stephen D Silberstein, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. JAMA 2018
204
18

Migraine and the trigeminovascular system-40 years and counting.
Messoud Ashina, Jakob Møller Hansen, Thien Phu Do, Agustin Melo-Carrillo, Rami Burstein, Michael A Moskowitz. Lancet Neurol 2019
98
18

Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier.
Rodrigo Noseda, Aaron J Schain, Agustin Melo-Carrillo, Jason Tien, Jennifer Stratton, Fanny Mai, Andrew M Strassman, Rami Burstein. Cephalalgia 2020
33
48


Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
Virginia L Stauffer, David W Dodick, Qi Zhang, Jeffrey N Carter, Jessica Ailani, Robert R Conley. JAMA Neurol 2018
222
17

Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study.
Holland C Detke, Peter J Goadsby, Shufang Wang, Deborah I Friedman, Katherine J Selzler, Sheena K Aurora. Neurology 2018
204
17




ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
David W Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet, Vera Osipova, Kerry Palmer, Hernan Picard, Daniel D Mikol, Robert A Lenz. Cephalalgia 2018
241
16

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.
Vladimir Skljarevski, Manjit Matharu, Brian A Millen, Michael H Ossipov, Byung-Kun Kim, Jyun Yan Yang. Cephalalgia 2018
199
16

Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier.
Sajedeh Eftekhari, Christopher A Salvatore, Sara Johansson, Tsing-Bau Chen, Zhizhen Zeng, Lars Edvinsson. Brain Res 2015
149
15

Origin of pain in migraine: evidence for peripheral sensitisation.
Jes Olesen, Rami Burstein, Messoud Ashina, Peer Tfelt-Hansen. Lancet Neurol 2009
348
15

Mechanisms of migraine aura revealed by functional MRI in human visual cortex.
N Hadjikhani, M Sanchez Del Rio, O Wu, D Schwartz, D Bakker, B Fischl, K K Kwong, F M Cutrer, B R Rosen, R B Tootell,[...]. Proc Natl Acad Sci U S A 2001
964
15

Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats.
Kirk W Johnson, S Michelle Morin, Victor J Wroblewski, Michael P Johnson. Cephalalgia 2019
37
35

CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP's Role in Migraine with Aura.
Aaron J Schain, Agustin Melo-Carrillo, Jennifer Stratton, Andrew M Strassman, Rami Burstein. J Neurosci 2019
24
54


Sensitization of meningeal sensory neurons and the origin of headaches.
A M Strassman, S A Raymond, R Burstein. Nature 1996
497
13






Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.
Hayrunnisa Bolay, Uwe Reuter, Andrew K Dunn, Zhihong Huang, David A Boas, Michael A Moskowitz. Nat Med 2002
798
12

CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior.
Aslı Filiz, Nermin Tepe, Sajedeh Eftekhari, H Evren Boran, Ergin Dilekoz, Lars Edvinsson, Hayrunnisa Bolay. Cephalalgia 2019
37
29

Brain stem activation in spontaneous human migraine attacks.
C Weiller, A May, V Limmroth, M Jüptner, H Kaube, R V Schayck, H H Coenen, H C Diener. Nat Med 1995
12

Spreading depression triggers headache by activating neuronal Panx1 channels.
Hulya Karatas, Sefik Evren Erdener, Yasemin Gursoy-Ozdemir, Sevda Lule, Emine Eren-Koçak, Zümrüt Duygu Sen, Turgay Dalkara. Science 2013
283
12


Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
David W Dodick, Peter J Goadsby, Stephen D Silberstein, Richard B Lipton, Jes Olesen, Messoud Ashina, Kerri Wilks, David Kudrow, Robin Kroll, Bruce Kohrman,[...]. Lancet Neurol 2014
244
11

In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232.
Eric D Hostetler, Aniket D Joshi, Sandra Sanabria-Bohórquez, Hong Fan, Zhizhen Zeng, Mona Purcell, Liza Gantert, Kerry Riffel, Mangay Williams, Stacey O'Malley,[...]. J Pharmacol Exp Ther 2013
84
11

Calcitonin gene-related peptide (CGRP): a new target for migraine.
Andrew F Russo. Annu Rev Pharmacol Toxicol 2015
183
11

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Marcelo E Bigal, David W Dodick, Alan M Rapoport, Stephen D Silberstein, Yuju Ma, Ronghua Yang, Pippa S Loupe, Rami Burstein, Lawrence C Newman, Richard B Lipton. Lancet Neurol 2015
190
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.